Document is current
Any future updates will be listed below
-
Authors
Marks, Markus https://orcid.org/0000-0001-8016-1637
Israel, Uriah
Dilip, Rohit
Li, Qilin
Yu, Changhua
Laubscher, Emily https://orcid.org/0009-0008-0242-0507
Iqbal, Ahamed
Pradhan, Elora
Ates, Ada
Abt, Martin https://orcid.org/0009-0001-6203-0702
Brown, Caitlin
Pao, Edward
Li, Shenyi https://orcid.org/0000-0002-7191-8965
Pearson-Goulart, Alexander
Perona, Pietro
Gkioxari, Georgia
Barnowski, Ross https://orcid.org/0009-0004-4184-8566
Yue, Yisong https://orcid.org/0000-0001-9127-1989
Van Valen, David https://orcid.org/0000-0001-7534-7621
- License Information
-
More Information
Article History
Received: 7 March 2024
Accepted: 21 September 2025
First Online: 8 December 2025
Competing interests
: D.V.V. is the scientific founder of Aizen Therapeutics and holds equity in the company. The other authors declare no competing interests.
